A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]

BACKGROUND: The WHO recommends that adults with uncomplicated P. falciparum successfully treated with a blood schizonticide receive a single dose of primaquine (PQ) 45 mg as a gametocytocidal agent. An earlier pilot study suggested that 75 mg of bulaquine (BQ), of which PQ is a major metabolite, may...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogtay, NJ, Kamtekar, KD, Dalvi, SS, Mehta, SS, Chogle, AR, Aigal, U, Kshirsagar, NA
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1389708/
https://www.ncbi.nlm.nih.gov/pubmed/16448575
http://dx.doi.org/10.1186/1471-2334-6-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1389708/
https://www.ncbi.nlm.nih.gov/pubmed/16448575
http://dx.doi.org/10.1186/1471-2334-6-16

Ejemplares similares